CLVT has been the subject of a number of other research reports. The Goldman Sachs Group reduced their price target on Clarivate from $17.00 to $14.50 and set a buy rating for the company in a report on Wednesday, November 9th. Morgan Stanley reduced their price target on Clarivate from $14.00 to $13.00 and set an overweight rating for the company in a report on Wednesday, November 9th. Wells Fargo & Company reduced their price target on Clarivate from $15.00 to $14.00 and set an overweight rating for the company in a report on Wednesday, November 9th. Finally, Royal Bank of Canada reduced their price target on Clarivate from $13.00 to $12.00 and set an outperform rating for the company in a report on Wednesday, November 9th. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of Moderate Buy and an average target price of $14.25.
Clarivate Stock Performance
NYSE CLVT opened at $9.84 on Monday. The stock has a market capitalization of $6.63 billion, a price-to-earnings ratio of -1.44 and a beta of 0.98. Clarivate has a twelve month low of $8.00 and a twelve month high of $25.63. The company has a current ratio of 0.89, a quick ratio of 0.89 and a debt-to-equity ratio of 1.16. The stock has a 50-day moving average of $9.80 and a 200 day moving average of $12.27.
Institutional Inflows and Outflows
Several hedge funds have recently added to or reduced their stakes in the business. Repertoire Partners LP purchased a new position in Clarivate in the third quarter worth approximately $939,000. Parallax Volatility Advisers L.P. acquired a new position in Clarivate during the third quarter worth $197,000. Integrated Investment Consultants LLC lifted its stake in Clarivate by 76.0% during the third quarter. Integrated Investment Consultants LLC now owns 19,885 shares of the company’s stock worth $187,000 after purchasing an additional 8,585 shares in the last quarter. Clarkston Capital Partners LLC lifted its stake in Clarivate by 86.1% during the third quarter. Clarkston Capital Partners LLC now owns 33,781,635 shares of the company’s stock worth $317,210,000 after purchasing an additional 15,626,160 shares in the last quarter. Finally, Alpha Paradigm Partners LLC acquired a new position in Clarivate during the third quarter worth $667,000. 83.42% of the stock is currently owned by hedge funds and other institutional investors.
Clarivate Company Profile
Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs.
- Get a free copy of the StockNews.com research report on Clarivate (CLVT)
- Three CBD Stocks to Dominate a Budding Industry
- Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
- Institutional Support for Analog Devices Remains High
- Microsoft Shares: Is it Time to Back Up the Truck?
- Is the 60/40 Portfolio Mix Still in Vogue?
Receive News & Ratings for Clarivate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarivate and related companies with MarketBeat.com's FREE daily email newsletter.